RxSight Inc (RXST)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
OPHTHALMIC GOODS
CEO:
Ronald M. Kurtz
Employees:
220
100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA 92656
949-521-7822

RxSight, Inc. engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. The company was formerly known as Calhoun Vision, Inc.

Data derived from most recent annual or quarterly report
Market Cap 444.932 Million Shares Outstanding27.722 Million Avg 30-day Volume 199.125 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.61
Price to Revenue7.1519 Debt to Equity0.4786 EBITDA-60.149 Million
Price to Book Value3.8984 Operating Margin-129.2072 Enterprise Value287.7 Million
Current Ratio7.806 EPS Growth0.325 Quick Ratio6.774
1 Yr BETA 1.0711 52-week High/Low 16.99 / 9.78 Profit Margin-136.2228
Operating Cash Flow Growth-31.6319 Altman Z-Score-1.7288 Free Cash Flow to Firm -49.136 Million
Earnings Report2023-05-04
View SEC Filings from RXST instead.

View recent insider trading info

RxSight Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding RXST (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RXST

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-10 by GOLDSHLEGER ILYA
  • 4: filed on 2023-03-10 by Thunen Shelley B
  • 4: filed on 2023-03-10 by WEINBERG ERIC
  • 4: filed on 2023-03-10 by KURTZ RONALD M MD
  • 4: filed on 2023-02-13 by TAMMENOMS BAKKER JULIET
  • 4: filed on 2023-02-13 by KURTZ RONALD M MD
  • 4: filed on 2023-01-23 by FOUNTAIN TAMARA
  • 4: filed on 2022-08-11 by LINK WILLIAM J PHD
  • 4: filed on 2022-06-09 by LINK WILLIAM J PHD
  • 4/A: filed on 2022-06-08 by LINK WILLIAM J PHD

    • Events (8k)

  • 8-K: filed on 2023-03-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-12:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-11:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    480 Thousand total shares from 1 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KURTZ RONALD M MD PRESIDENT & CEO

    • Officer
    • Director
    		 0 2023-03-09 2

    WEINBERG ERIC CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2023-03-09 1

    THUNEN SHELLEY B CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-03-09 1

    GOLDSHLEGER ILYA CHIEF OPERATING OFFICER

    • Officer
    		 0 2023-03-09 1

    TAMMENOMS BAKKER JULIET

    • Director
    		 2,997,321 2023-02-10 2

    FOUNTAIN TAMARA

    • Director
    		 23,508 2023-01-19 1

    LINK WILLIAM J PHD

    • Director
    		 901,257 2022-11-09 6

    PALMISANO ROBERT J

    • Director
    		 22,002 2022-06-02 1

    ANDREWS JULIE

    • Director
    		 37,627 2022-06-02 1

    MANIAR SHWETA

    • Director
    		 23,508 2022-06-02 1

    WARNER ROBERT KEITH

    • Director
    		 65,752 2022-06-02 1

    CORLEY JESSE ANDERSON

    • Director
    		 460,559 2022-06-02 1

    ROBERTSON BRUCE C

    • Director
    		 1,385,037 2021-08-03 0

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • 10% Owner
    		 3,052,796 2021-08-03 0

    RXSIGHT I, LLC

    • 10% Owner
    		 0 2021-08-03 0

    WOLFEN RICHARD M.

    • Director
    		 1,840,244 2021-08-03 0

    SCHWARTZ DANIEL MARK

    • Director
    		 407,647 2021-08-03 0

    COX CHRISTOPHER

    • Director
    		 0 2021-07-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    WEINBERG ERIC - Officer CHIEF COMMERCIAL OFFICER

    		2023-03-10 16:11:36 -0500 2023-03-09 A 95,000 a 95,000 direct

    KURTZ RONALD M MD - Director - Officer PRESIDENT & CEO

    		2023-03-10 16:10:23 -0500 2023-03-09 A 200,000 a 200,000 direct

    GOLDSHLEGER ILYA - Officer CHIEF OPERATING OFFICER

    		2023-03-10 16:14:13 -0500 2023-03-09 A 120,000 a 120,000 direct

    THUNEN SHELLEY B - Officer CHIEF FINANCIAL OFFICER

    		2023-03-10 16:13:04 -0500 2023-03-09 A 120,000 a 120,000 direct

    KURTZ RONALD M MD - Director - Officer PRESIDENT & CEO

    		2023-02-13 18:19:14 -0500 2023-02-10 A 40,000 $12.50 a 40,000 direct -0.9306 -2.0759 0.0 1 -5.4402 3

    TAMMENOMS BAKKER JULIET - Director see footnote

    		2023-02-13 18:20:29 -0500 2023-02-10 P 480,000 $12.50 a 980,000 indirect -0.9306 -2.0759 0.0 1 -5.4402 3

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    RXSIGHT INC RXST 2023-03-24 22:15:03 UTC 3.3166 1.5034 100000
    RXSIGHT INC RXST 2023-03-24 21:45:03 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 21:15:03 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 20:45:03 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 20:15:04 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 19:45:03 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 19:15:04 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 18:45:04 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 18:15:03 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 17:45:03 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 17:15:03 UTC 3.3157 1.5043 100000
    RXSIGHT INC RXST 2023-03-24 16:45:03 UTC 3.3268 1.4932 100000
    RXSIGHT INC RXST 2023-03-24 16:15:03 UTC 3.3268 1.4932 85000
    RXSIGHT INC RXST 2023-03-24 15:45:03 UTC 3.3268 1.4932 85000
    RXSIGHT INC RXST 2023-03-24 15:15:03 UTC 3.3268 1.4932 85000
    RXSIGHT INC RXST 2023-03-24 14:45:03 UTC 3.3268 1.4932 85000
    RXSIGHT INC RXST 2023-03-24 14:15:03 UTC 3.3268 1.4932 85000
    RXSIGHT INC RXST 2023-03-24 13:45:03 UTC 3.089 1.481 85000
    RXSIGHT INC RXST 2023-03-24 13:15:04 UTC 3.089 1.481 85000
    RXSIGHT INC RXST 2023-03-24 12:45:03 UTC 3.089 1.481 85000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    INVESTMENT MANAGERS SERIES TRUST- 361 Domestic Long/Short Equity Fund RXST -237.0 shares, $-2948.28 2022-10-31 N-PORT
    LoCorr Investment Trust- LoCorr Dynamic Equity Fund RXST -7273.0 shares, $-92148.91 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments